| Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic … Y Nishimura, DC Fajgenbaum, SK Pierson, N Iwaki, A Nishikori, ... American Journal of Hematology 96 (10), 1241-1252, 2021 | 73 | 2021 |
| Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer T Ikeda, Y Gion, M Sakamoto, T Tachibana, A Nishikori, MF Nishimura, ... Modern Pathology 33 (12), 2437-2448, 2020 | 50 | 2020 |
| Epstein–Barr virus-positive mucocutaneous ulcer: a unique and curious disease entity T Ikeda, Y Gion, Y Nishimura, MF Nishimura, T Yoshino, Y Sato International journal of molecular sciences 22 (3), 1053, 2021 | 41 | 2021 |
| Investigation of IgG4‐positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4‐related disease A Nishikori, MF Nishimura, Y Nishimura, K Notohara, A Satou, ... Pathology International 72 (1), 43-52, 2022 | 20 | 2022 |
| Primary gastrointestinal T-cell lymphoma and indolent lymphoproliferative disorders: Practical diagnostic and treatment approaches MF Nishimura, Y Nishimura, A Nishikori, T Yoshino, Y Sato Cancers 13 (22), 5774, 2021 | 18 | 2021 |
| Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease: a clinicopathological study in comparison with IgG4-related disease MF Nishimura, T Igawa, Y Gion, S Tomita, D Inoue, A Izumozaki, Y Ubara, ... Journal of Personalized Medicine 10 (4), 269, 2020 | 18 | 2020 |
| Idiopathic plasmacytic lymphadenopathy forms an independent subtype of idiopathic multicentric Castleman disease A Nishikori, MF Nishimura, Y Nishimura, F Otsuka, K Maehama, ... International journal of molecular sciences 23 (18), 10301, 2022 | 16 | 2022 |
| Historical and pathological overview of Castleman disease MF Nishimura, Y Nishimura, A Nishikori, T Yoshino, Y Sato Journal of clinical and experimental hematopathology 62 (2), 60-72, 2022 | 15 | 2022 |
| International definition of iMCD-TAFRO: future perspectives Y Nishimura, MF Nishimura, Y Sato Journal of clinical and experimental hematopathology 62 (2), 73-78, 2022 | 12 | 2022 |
| Clinical and pathological characteristics of hyaline-vascular type unicentric castleman disease: a 20-year retrospective analysis MF Nishimura, Y Nishimura, A Nishikori, Y Maekawa, K Maehama, ... Diagnostics 11 (11), 2008, 2021 | 9 | 2021 |
| Clinicopathological characteristics of gastric IgG4‐related disease: Systematic scoping review H Sawada, T Czech, K Silangcruz, L Kozai, A Obeidat, EA Wien, ... Journal of Gastroenterology and Hepatology 37 (10), 1865-1872, 2022 | 6 | 2022 |
| Upregulated expression of activation-induced cytidine deaminase in ocular adnexal marginal zone lymphoma with IgG4-positive cells A Nishikori, Y Nishimura, R Shibata, K Ohshima, Y Gion, T Ikeda, ... International journal of molecular sciences 22 (8), 4083, 2021 | 6 | 2021 |
| Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease? Y Nishimura, A Nishikori, H Sawada, T Czech, Y Otsuka, MF Nishimura, ... Journal of clinical and experimental hematopathology 62 (2), 99-105, 2022 | 5 | 2022 |
| Cytopathological findings of secretory carcinoma of the salivary gland and the diagnostic utility of Giemsa staining Y Egusa, MF Nishimura, S Baba, K Takeuchi, T Makino, T Tachibana, ... Diagnostics 11 (12), 2284, 2021 | 5 | 2021 |
| Hematopoietic stem cell–derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide Y Sumii, T Kondo, S Ikegawa, T Fukumi, M Iwamoto, MF Nishimura, ... JCI insight 8 (8), 2023 | 4 | 2023 |
| PD‐L1 expression is associated with the spontaneous regression of patients with methotrexate‐associated lymphoproliferative disorders Y Gion, M Doi, Y Nishimura, T Ikeda, M Filiz Nishimura, M Sakamoto, ... Cancer medicine 11 (2), 417-432, 2022 | 4 | 2022 |
| Triple-negative pleomorphic lobular carcinoma and expression of androgen receptor: Personal case series and review of the literature K Taniguchi, S Takada, M Omori, T Igawa, MF Nishimura, T Morito, ... PloS one 15 (7), e0235790, 2020 | 4 | 2020 |
| Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4 … A Nishikori, MF Nishimura, DC Fajgenbaum, Y Nishimura, K Maehama, ... Journal of Clinical Pathology, 2024 | 3 | 2024 |
| Clinical characteristics and outcomes of IgG4‐positive marginal zone lymphoma: Systematic scoping review Y Nishimura, EA Wien, MF Nishimura, A Nishikori, Y Sato, F Otsuka Pathology International 72 (7), 361-370, 2022 | 3 | 2022 |
| Comparison of serum sIL-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma Y Hirami, MF Nishimura, T Urata, M Morimoto, Y Maekawa, T Yoshino, ... Journal of clinical and experimental hematopathology 63 (1), 25-31, 2022 | 3 | 2022 |
Yoshito NishimuraMayo Clinic在 hawaii.edu 的电子邮件经过验证
Yoshito NishimuraMayo Clinic在 hawaii.edu 的电子邮件经过验证
David C FajgenbaumTranslational Medicine & Human Genetics, University of Pennsylvania在 pennmedicine.upenn.edu 的电子邮件经过验证